GURU.Markets stock price, segment price, and overall market index valuation
The company's share price AXNX
Axonics revolutionized the treatment of overactive bladder with its miniature neuromodulation system. Its stock price is a story of rapid growth, driven by displacing competitors' products and expanding the market with a more convenient and durable technology.
Share prices of companies in the market segment - Specialized medical equipment
Axonics is a medical company that develops and markets implantable devices for the treatment of bladder and bowel dysfunctions. We've classified it as a "Specialized Medical Equipment" company. The chart below shows how the market values innovative solutions in urology.
Broad Market Index - GURU.Markets
Axonics is a medical company that develops and markets implantable devices for the treatment of bladder and bowel dysfunction. As a component of the GURU.Markets index, it is a leader in its niche. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
AXNX - Daily change in the company's share price AXNX
Axonics, Inc.'s daily stock price reflects volatility in the medical device sector. This metric is a measure of the company's sensitivity to sales of its neurostimulators and competition in the pelvic floor dysfunction treatment market.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Axonics develops and markets implantable devices for the treatment of bladder and bowel dysfunction. The neuromodulation market is growing rapidly. The chart below shows the average volatility in the medical device sector, allowing you to compare AXNX's performance with its competitors.
Daily change in the price of a broad market stock, index - GURU.Markets
Axonics is a leading developer of implantable devices for the treatment of bladder and bowel dysfunction. This medtech company's stock price reflects the demand for solutions that improve quality of life. Its share price reflects the contribution of innovative medicine to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization AXNX
Axonics, Inc.'s year-over-year performance tells the story of its rapid growth in the sacral neuromodulation market. Its 12-month market cap growth reflects its success in capturing market share from giant Medtronic. Its miniaturized and durable implants for treating bladder and bowel dysfunction have become a popular choice among doctors and patients.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Axonics, Inc. is a fast-growing medical device company that has developed innovative implantable devices for the treatment of bladder dysfunction. This chart shows how its breakthrough technology is allowing it to capture market share from giants and significantly outpace the growth of the medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Axonics, a fast-growing medical technology company, offers implantable devices for the treatment of bladder and bowel dysfunction. Its year-over-year market capitalization reflects its successful commercial launch and market share gains from competitors. It's a growth story, often outpacing the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization AXNX
Axonics is a fast-growing medical technology company producing devices for the treatment of bladder and bowel dysfunction. Its month-over-month performance reflects quarterly revenue growth reports that outpace the market and its competitiveness with major players.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Axonics, Inc. is a rapidly growing company that produces implantable devices for the treatment of bladder and bowel dysfunction. This medical technology sector improves the quality of life for millions of people. The chart below shows how investors assessed the prospects of innovative neuromodulation methods and their competition with traditional treatments.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Axonics is a fast-growing medical company producing implantable devices for the treatment of bladder dysfunction. Its stock is a story of commercial success and market share capture from competitors. Its performance reflects strong sales growth rather than the overall economic situation.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization AXNX
Shares of Axonics, a maker of implantable devices for bladder dysfunction, reflect trends in MedTech. Weekly price movements are driven by sales data, competition with Medtronic, and demographic trends. The chart below shows how short-term commercial and market events impact the valuation of this fast-growing player.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Axonics is a fast-growing company producing implantable devices for the treatment of bladder and bowel dysfunction. It is successfully capturing market share from the market leader. The chart will show how its aggressive growth and innovation are enabling it to outperform the slower-moving medical device sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Axonics is a medical equipment company. This chart compares its weekly performance to the broader market. It helps understand how resilient its business, focused on the stable healthcare sector, is to the general economic downturns that affect the overall stock market.
Market capitalization of the company, segment and market as a whole
AXNX - Market capitalization of the company AXNX
Axonics, Inc.'s market capitalization is a successful challenger to a market leader. Its market capitalization chart reflects the rapid growth of its sacral neuromodulation systems for bladder dysfunction. The dynamics show how investors assess its ability to win market share from giant Medtronic.
AXNX - Share of the company's market capitalization AXNX within the market segment - Specialized medical equipment
Axonics' market share in the specialized medical device sector reflects its rapid growth and success in treating bladder and bowel dysfunction. Its significant market share reflects how its miniature neurostimulators successfully compete with products from much larger companies.
Market capitalization of the market segment - Specialized medical equipment
This chart shows the total market capitalization of manufacturers of medical devices for the treatment of pelvic floor dysfunction. Axonics is one of the leaders and disruptors in this niche. The dynamics in the chart reflect rapid growth and successful capture of market share from an established, dominant player.
Market capitalization of all companies included in a broad market index - GURU.Markets
This graph depicts the market value of a technology that restores control over pelvic floor function. Axonics, Inc.'s market capitalization is based on the valuation of its implantable neurostimulators. The line shows how a medical device that improves quality of life is gaining significant market share in the global industry.
Book value capitalization of the company, segment and market as a whole
AXNX - Book value capitalization of the company AXNX
This is an assessment of the assets of Axonics, Inc. The chart reflects the value of its manufacturing facilities and, more importantly, patents for implantable sacral neuromodulation systems that treat bladder and bowel dysfunction. The growth of this line indicates investment in this rapidly growing medical technology.
AXNX - Share of the company's book capitalization AXNX within the market segment - Specialized medical equipment
Axonics' tangible assets include its US manufacturing facilities for the creation of implantable devices for the treatment of bladder and bowel dysfunction. The chart shows the company's share of this high-tech medical infrastructure, which improves the quality of life for millions of people.
Market segment balance sheet capitalization - Specialized medical equipment
As the chart shows, medical equipment manufacturing is a capital-intensive industry. Axonics is a prime example. Mass production of its implantable neurostimulators requires modern manufacturing facilities. The company is consciously investing in this physical base.
Book value of all companies included in the broad market index - GURU.Markets
Axonics is a leader in the production of implantable devices for the treatment of overactive bladder and incontinence. The company's assets include high-tech factories where these "neurostimulators" for body control are created. The chart below illustrates the company's physical scale in this medical technology niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - AXNX
Axonics is a fast-growing company producing implantable devices for the treatment of bladder and bowel dysfunction. Its assets include technology and manufacturing capacity. The chart below shows the premium the market is paying for its innovative products and its rapid market share capture from competitors.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Axonics, Inc. is a medical technology company developing devices for the treatment of bladder and bowel dysfunction. Its value lies in innovative products that improve quality of life. This chart shows the premium the market is paying for its rapid growth and technology.
Market to book capitalization ratio for the market as a whole
Axonics develops and markets implantable medical devices for the treatment of bladder and bowel dysfunction. This chart shows how the market views their innovative products and their ability to capture market share from the market leader. It's a story of growth and technological innovation in medtech.
Debts of the company, segment and market as a whole
AXNX - Company debts AXNX
Axonics, a fast-growing medical technology company, is using debt financing to support its commercial expansion. It produces implantable devices for the treatment of bladder and bowel dysfunction. This chart shows how the company is investing in its sales and marketing to gain market share from a larger competitor.
Market segment debts - Specialized medical equipment
Axonics is a fast-growing medical technology company producing implantable devices for the treatment of bladder and bowel dysfunction. This chart shows how its leverage reflects its aggressive growth strategy, requiring significant investments in R&D, marketing, and sales to compete with the established market leader.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio AXNX
Atlantica is a company that owns a portfolio of long-term infrastructure assets, such as power plants (including renewable ones), transmission lines, and desalination plants. The chart shows the high debt levels typical for this sector, supported by stable and predictable cash flows from these assets.
Market segment debt to market segment book capitalization - Specialized medical equipment
Axonics is a medical device company that developed a sacral neuromodulation system for the treatment of bladder and bowel dysfunction. This chart compares its debt to the overall market capitalization of the entire sector. It shows how the fast-growing company is funding its commercial expansion and competing with the giant Medtronic.
Debt to book value of all companies in the market
Axonics, Inc. has successfully commercialized innovative devices for the treatment of bladder and bowel dysfunction. In the medtech sector, rapid growth requires significant investment in sales and marketing. This chart of overall debt trends helps assess how effectively Axonics is using capital to capture market share from older technologies.
P/E of the company, segment and market as a whole
P/E - AXNX
This chart shows the high valuation of Axonics, a fast-growing medical technology company. The high P/E reflects the success of its implantable devices for bladder dysfunction. Investors are paying for its rapid market share growth and innovation in neuromodulation.
P/E of the market segment - Specialized medical equipment
Axonics is a fast-growing medical technology company that has developed and commercialized implantable systems for the treatment of bladder and bowel dysfunction. Its products compete with solutions from major players. This chart shows the average valuation for the specialized medical device sector, reflecting how investors value disruptive technologies that improve patients' quality of life.
P/E of the market as a whole
Axonics is a rapidly growing medical technology company that develops and markets implantable devices for the treatment of bladder and bowel dysfunction. The company's products significantly improve patients' quality of life. This chart provides an overview of how the market views innovative companies in the medical device sector.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company AXNX
Axonics is a medical company that has developed an implantable system for the treatment of overactive bladder and incontinence. This chart illustrates future revenue expectations, which depend on the growing number of patients choosing this technology and competition in the neuromodulation market.
%20P%2FE%20AXNX&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-AXNX&v=1772511611370 "Chart of the company's future (projected) P/E AXNX")
Future (projected) P/E of the market segment - Specialized medical equipment
Axonics is a fast-growing medical technology company producing implantable devices for the treatment of bladder and bowel dysfunction. This chart shows how the market perceives its ability to gain market share from market leader Medtronic. It compares Axonics' growth expectations with those of the medical device sector.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772511611379 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Axonics Inc. develops and markets innovative medical devices for the treatment of bladder and bowel dysfunction. Demand for their products is driven by an aging population and a desire for improved quality of life. This trend, reflecting overall economic confidence, influences the willingness of patients and healthcare systems to pay for advanced medical solutions.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772511611384 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit AXNX
Axonics is a medical device company specializing in devices for the treatment of bladder and bowel dysfunction. Its financial results are directly dependent on growing sales of its sacral neuromodulation systems. This chart shows how successful competition and market expansion are driving the company's rapid revenue growth.
Profit of companies in the market segment - Specialized medical equipment
Axonics, Inc. is a medical technology company developing and marketing innovative solutions for the treatment of bladder and bowel dysfunction. This graph, showing overall sector profitability, reflects the demand for improved quality of life. The success of Axonics' miniaturized and durable neurostimulators directly impacts treatment standards and industry profitability.
Overall market profit
Axonics is a rapidly growing medical technology company that has developed an implantable system for the treatment of overactive bladder and urinary incontinence. Its products offer an effective alternative for millions of patients, improving their quality of life.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company AXNX
Axonics develops and markets implantable medical devices for the treatment of bladder and bowel dysfunction. Future revenue projections depend on the growing number of patients choosing their therapy and expanding market penetration.
%20profit%20of%20the%20company%20AXNX&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-AXNX&v=1772511611396 "Graph of future (projected) profit of the company AXNX")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Axonics develops and markets innovative medical devices for the treatment of bladder and bowel dysfunction. This chart shows overall profitability forecasts for the specialized medical device sector. It helps understand how the company's products, which improve the quality of life for millions of people, compare to overall trends in neuromodulation.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772511611398 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Axonics is a fast-growing medical technology company developing devices for the treatment of bladder and bowel dysfunction. Demand for its products is driven by improved quality of life. This chart is important because during periods of economic growth and confidence, consumers and healthcare systems are more willing to spend on effective, but not always urgent, procedures.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772511611400 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - AXNX
Axonics is a fast-growing medical technology company producing implantable devices for the treatment of bladder and bowel dysfunction. This metric, which relates market capitalization to revenue, reflects its successful market penetration. It demonstrates the high premium investors are paying for its innovative products and rapid sales growth.
P/S market segment - Specialized medical equipment
Axonics, Inc. has developed and commercialized an innovative sacral neuromodulation system for the treatment of overactive bladder and urinary incontinence. The company offers a rechargeable and durable solution. This chart shows the high premium the market is willing to pay for revenue in the medical technology sector, reflecting Axonics' rapid growth and market share.
P/S of the market as a whole
Axonics, Inc. has developed and commercialized an innovative sacral neuromodulation system for the treatment of overactive bladder and incontinence. The company successfully competes with the market leader. This chart shows the premium the market is willing to pay for the revenue of a rapidly growing medical technology company.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company AXNX
Axonics develops and markets implantable devices for the treatment of bladder and bowel dysfunction. This chart shows how investors value the company based on its projected future sales. It reflects their belief in the growth of the neuromodulation market and Axonics' ability to capture market share from competitors.
%20P%2FS%20AXNX&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-AXNX&v=1772511611414 "The graph of the company's future (projected) P/S AXNX")
Future (projected) P/S of the market segment - Specialized medical equipment
Axonics is a medical technology company that develops and markets innovative devices for the treatment of bladder and bowel dysfunction. The chart shows the average future revenue estimates for medical device manufacturers. It helps understand how highly investors value Axonics' products and its ability to capture market share from longtime leader Medtronic.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772511611415 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Axonics (AXNX) produces and markets innovative medical devices for the treatment of bladder and bowel dysfunction. Demand for their products is driven by an aging population and the desire for improved quality of life. This trend is less important to them than demographic trends and the adoption of their technology in medical practice.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772511611420 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales AXNX
Axonics' revenue is generated in the rapidly growing bladder and bowel dysfunction treatment market. The company sells implantable neurostimulators, which are an alternative to traditional therapy. This growth reflects the company's aggressive competitive squeeze and strong demand for its more modern and patient-friendly technology.
Sales of companies in the market segment - Specialized medical equipment
Axonics, Inc. manufactures and markets implantable devices for the treatment of bladder and bowel dysfunction. Its sales breakdown shows how much revenue comes from its core sacral neuromodulation system and how much from new products, reflecting its rapid growth in this market.
Overall market sales
Axonics, Inc. develops and markets medical devices for the treatment of bladder and bowel dysfunction. Demand for its quality-of-life products depends on insurance coverage and patient disposable income. This curve, reflecting overall economic health, influences patients' ability to pay their share of costs and the willingness of the healthcare system to cover such therapies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company AXNX
Axonics is a medical device company that has developed an innovative system for the treatment of overactive bladder and incontinence. This chart shows analysts' expectations for neuromodulation market growth and the displacement of legacy technologies.
%20sales%20of%20the%20company%20AXNX&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-AXNX&v=1772511611440 "Schedule of future (projected) sales of the company AXNX")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Axonics, Inc. develops and markets innovative devices for the treatment of bladder and bowel dysfunction, such as sacral neuromodulation. This chart shows the forecast for the specialized medical device sector. It reflects the demand for effective and long-term solutions to improve the quality of life of millions of patients.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772511611443 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
This chart illustrating healthcare costs is important for Axonics. The company produces implantable devices for the treatment of bladder and bowel dysfunction. Demand for its products depends on patient affordability and insurance coverage, which is directly linked to the overall health of the economy.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772511611448 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality AXNX
Axonics is a fast-growing medical technology company that develops and markets implantable devices for the treatment of bladder and bowel dysfunction. This chart demonstrates the high profitability of its innovative products. This profitability is driven by strong demand and technological superiority over competitors.
Market segment marginality - Specialized medical equipment
Axonics produces innovative medical devices for the treatment of bladder and bowel dysfunction, such as neurostimulators. Profitability depends on the successful implementation of its products. This chart shows the average profitability in the sector. It helps assess how successfully Axonics competes in the sacral neuromodulation market.
Market marginality as a whole
Axonics develops and markets implantable devices for the treatment of bladder and bowel dysfunction. Demand for its products is driven by the aging population and patients' willingness to seek solutions to improve their quality of life. This dynamic, reflecting the overall economic situation, impacts the ability of patients and the insurance systems that cover these procedures.
Employees in the company, segment and market as a whole
Number of employees in the company AXNX
Axonics, Inc. has developed and successfully commercialized an innovative sacral neuromodulation system for the treatment of bladder and bowel dysfunction. This graph shows a rapidly growing team of sales specialists and clinicians. This rapid growth reflects the successful capture of market share from a competitor and strong demand for their product.
Share of the company's employees AXNX within the market segment - Specialized medical equipment
Axonics is a fast-growing company that developed a sacral neuromodulation system for the treatment of overactive bladder and incontinence. This chart shows its share of the overall medical device market share. This reflects its successful competition with Medtronic and its rapid market capture.
Number of employees in the market segment - Specialized medical equipment
Axonics, Inc. develops and markets innovative medical devices for the treatment of bladder and bowel dysfunction, such as sacral neuromodulation. This chart, showing employment in the specialized medical device sector, is important. The growing number of urologists and engineers in this field demonstrates the demand for minimally invasive and effective solutions to improve quality of life.
Number of employees in the market as a whole
Axonics develops and markets implantable devices for the treatment of bladder and bowel dysfunction. This overall employment rate reflects patients' ability to afford quality-of-life procedures. Stable employment and good insurance coverage are often decisive factors for patients considering such advanced medical devices.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company AXNX (AXNX)
Axonics (AXNX) is a company that manufactures implantable medical devices (neurostimulators) for the treatment of bladder and bowel dysfunction. This business requires strong R&D (intellectual capital) and high-precision manufacturing. This metric reflects the high market valuation of their FDA-approved technologies.
%20of%20the%20company%20AXNX%20(AXNX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-AXNX-AXNX&v=1772511611479 "Chart of market capitalization per employee (in thousands of dollars) of the company AXNX (AXNX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Axonics produces implantable devices for the treatment of bladder and bowel dysfunction. This is a fast-growing medical device market. The chart helps assess how effectively the company is scaling its business. A high market capitalization per employee may indicate a strong market position and high product profitability.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772511611482 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Axonics is a medical device company specializing in the development of implantable devices for the treatment of bladder and bowel dysfunction. The high employee rating reflects the value of its innovative products, which significantly improve patients' quality of life and offer a high-tech alternative to existing treatments.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772511611489 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company AXNX (AXNX)
Axonics is a fast-growing medical technology company producing implantable devices for the treatment of bladder and bowel dysfunction (neuromodulation). They have taken on the giant Medtronic. This chart shows how profitable their strategy is: how effectively their sales team (salespeople training surgeons) generates revenue from the sale of these high-margin implants.
%20Chart%20AXNX%20(AXNX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-AXNX-AXNX&v=1772511611493 "Company Profit Per Employee (in thousands of dollars) Chart AXNX (AXNX)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Axonics, Inc. develops and markets innovative medical devices for the treatment of bladder and bowel dysfunction. This chart shows the commercial success of their products. The rapid growth of this metric demonstrates strong demand for their technology from physicians and patients, allowing the company to gain market share from competitors.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772511611496 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Axonics (AXNX) is a MedTech company that produces implantable neurostimulators for the treatment of bladder and bowel dysfunction. It's a rapidly growing business. This chart shows how the innovative medical implant enables high profitability per employee thanks to its high product margins.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772511611499 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee AXNX (AXNX)
Axonics, Inc. is a fast-growing company producing implantable devices for the treatment of bladder and bowel dysfunction. This chart shows the rapid growth of their innovative product sales. Their high revenue per employee reflects the effectiveness of their sales team.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-AXNX-AXNX&v=1772511611512 "Sales chart per company employee AXNX (AXNX)")
Sales per employee in the market segment - Specialized medical equipment
Axonics is a company whose implantable devices (sacral neuromodulation) treat urinary incontinence. They successfully compete with Medtronic. This chart shows how productive their sales team is. It reflects their ability to convince doctors and patients to use their high-tech (and expensive) implants.
Sales per employee for the market as a whole
Healthcare Services (HCSG) provides outsourced services for long-term care facilities (nursing homes), primarily cleaning, laundry, and dietary meals. It's a business that's critically dependent on staff. This chart is a barometer of service sector efficiency. HCSG manages thousands of low-wage employees. An increase in this metric indicates the company is successfully managing this workforce and controlling labor costs.
Short shares by company, segment and market as a whole
Shares shorted by company AXNX (AXNX)
Axonics (AXNX) produces implantable devices for the treatment of bladder dysfunction, directly competing with Medtronic. This chart shows the number of short positions. The short positions may be related to a fierce patent war with Medtronic, which, if lost, could kill Axonics' business.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-AXNX-AXNX&v=1772511611524 "Short Shares Chart for the Company AXNX (AXNX)")
Shares shorted by market segment - Specialized medical equipment
Axonics (AXNX) produces implantable devices (neurostimulators) for the treatment of bladder and bowel dysfunction. The chart below shows the overall short position on the medical device sector. It shows how much investors believe in growth in this market or anticipate increased competition.
Shares shorted by the overall market
Axonics (AXNX) produces implants for the treatment of bladder dysfunction. These are often "elective" procedures. When this fear graph rises, investors anticipate a recession. During such periods, patients postpone "non-urgent" but expensive surgeries, which directly impacts demand.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator AXNX (AXNX)
This chart for Axonics is a success story in medical devices. The company "burst" into the bladder stimulator market, taking share from Medtronic. "Overbought" levels (above 70) arise from strong sales growth reports. "Oversold" levels (below 30) could be caused by patent lawsuits or a general correction in the MedTech sector.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-AXNX-AXNX&v=1772511611538 "RSI 14 indicator chart for the company's stock AXNX (AXNX)")
RSI 14 Market Segment - Specialized medical equipment
Axonics is a "remote control" for the *bladder*. They are the *leader* (competitor to Medtronic) in *neuromodulation* (SNM) – implants that *control* overactive bladder and bowel. The "Specialized medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps to differentiate: is AXNX's growth a niche or a general "overheating"?
RSI 14 for the overall market
Axonics (AXNX) produces implants. This chart is an indicator of elective cosmetic surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people postpone non-urgent surgeries for fear of losing their insurance.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AXNX (AXNX)
Axonics is a fast-growing medical technology company that has transformed the overactive bladder treatment market. Their implantable neurostimulators (SNMs) compete with Medtronic. This chart shows the analysts' average 12-month forecast, reflecting their view of how Axonics continues to gain market share.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AXNX-AXNX&v=1772511611558 "A chart showing analyst consensus forecasts for the expected stock price. AXNX (AXNX)")
The difference between the consensus estimate and the actual stock price AXNX (AXNX)
Axonics (AXNX) is a game-changer in urology. The company produces implantable neurostimulators for the treatment of urinary and bowel incontinence. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe they can continue to gain market share from Medtronic.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AXNX-AXNX&v=1772511611560 "A chart showing the difference between the consensus forecast and the actual stock price. AXNX (AXNX)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Axonics (AXNX) is a fast-growing medical device company that has challenged Medtronic. It produces implantable neurostimulators for the treatment of incontinence (bladder and bowel). This chart shows general expectations for the specialized medical device sector. It reflects whether experts believe this "quality of life" market will grow.
Analysts' consensus forecast for the overall market share price
Axonics (AXNX) is a "pacemaker... for the bladder." They made a breakthrough by creating miniature implants that treat incontinence (neuromodulation). This chart shows the general sentiment of experts. It reflects the analysts' confidence in the stability of the healthcare system and the willingness of patients to undergo "elective" surgeries to improve their quality of life.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index AXNX
Axonics is a MedTech monopoly buster. Their signature device is an implantable neurostimulator (SNM), which treats overactive bladder (incontinence). They disrupted the market by offering a rechargeable, long-lasting implant. This chart summarizes their growth story. It reflects their rapidly growing market share and high margins.
AKIMA Market Segment Index - Specialized medical equipment
Axonics is a company that improves quality of life. They produce implantable neurostimulators for the treatment of bladder and bowel problems. They are a high-tech, specialized healthcare company. This chart compares their composite index to the sector, showing how their solutions outperform their competitors.
The AKIM Index for the overall market
Axonics is a medtech company that developed sacral neuromodulation systems for the treatment of bladder and bowel dysfunction. It is being acquired by Boston Scientific. This chart, which reflects the market average, is a backdrop. It helps assess how this successful growth story compared to the pre-merger market.
